首頁 > 市場調查報告書 > 製藥

骨疾病

中東和非洲骨關節炎治療市場預測至 2030 年 - 區域分析 - 按治療類型、疾病適應症和最終用戶

市場調查報告書

商品編碼

1562201

中東和非洲骨關節炎治療市場預測至 2030 年 - 區域分析 - 按治療類型、疾病適應症和最終用戶

Middle East & Africa Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 101 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年中東和非洲骨關節炎治療市場價值為4.600億美元，預計2030年將達到7.6298億美元；預計2022年至2030年複合年成長率為6.5%。

骨關節炎盛行率上升推動了中東和非洲骨關節炎治療市場

根據 CDC 報告，在全球範圍內，OA 影響著超過 5 億人，佔世界人口的 7%。它是長期殘疾的主要原因。此外，骨關節炎在運動員和遭受關節損傷或創傷的人中也更為常見。此外，女性更為常見，佔全球骨關節炎病例的 60%。根據世界衛生組織（WHO）的報告，骨關節炎在老年族群中更為常見。此外，骨關節炎可以影響任何人，但這種情況在 40 歲以上的成年人中最常見。此外，世界衛生組織的報告進一步顯示，約73%的骨關節炎患者年齡超過55歲，其中60%是女性。因此，隨著 OA 盛行率的上升，生物療法等新的治療方案正在全世界受到關注。富血小板血漿 (PRP) 療法就是一個例子，它已成為治療 OA 患者的一種有希望的治療方法。 PRP 透過催化身體的自然癒合和組織修復過程來增強組織恢復。

經皮神經電刺激 (TENS) 是治療 OA 的另一個例子。 TENS 透過減少對藥物的需求來幫助減輕急性和慢性疼痛。因此，骨關節炎盛行率的上升加速了對創新治療方案的需求，從而在未來幾年減少對藥物的依賴。

中東和非洲骨關節炎治療市場概述

中東和非洲地區分為沙烏地阿拉伯、南非、阿拉伯聯合大公國以及其他中東和非洲國家。肥胖率上升、生活型態和飲食模式的改變是中東和非洲地區骨關節炎藥物需求加速的最重要因素。根據美國國立衛生研究院 (NIH) 的報告，骨關節炎是最常見的關節炎形式。在南非，城市環境中，這一比例佔 55.1%；在農村地區，這一比例從 29.5% 到 29.7% 不等，在 65 歲以上人口中這一比例高達 82.7%。醫生提出了幾種治療骨關節炎的治療方案。治療包括非類固醇抗發炎藥 (NSAID)，例如布洛芬。因此，骨關節炎治療方案的可用性是 2022-2030 年市場成長的主要因素。

中東和非洲骨關節炎治療市場收入及 2030 年預測（百萬美元）

中東和非洲骨關節炎治療市場區隔

中東和非洲骨關節炎治療市場按治療類型、疾病適應症、最終用戶和國家分類。

依治療類型，中東和非洲骨關節炎治療市場分為經皮神經電刺激（TENS）、職能治療、物理治療、富血小板血漿（PRP）治療和基質血管成分、增生療法等。 2022 年，物理治療領域佔據最大的市場。

從疾病適應症來看，中東和非洲骨關節炎治療市場分為膝骨關節炎、脊椎骨關節炎、足踝骨關節炎、肩骨關節炎、手骨關節炎等。 2022 年，膝骨關節炎細分市場在中東和非洲骨關節炎治療市場中佔最大佔有率。

根據最終用戶，中東和非洲骨關節炎治療市場分為醫院和診所、專科診所、門診手術中心、家庭護理等。 2022 年，家庭護理領域在中東和非洲骨關節炎治療市場中佔據最大佔有率。

按國家/地區分類，中東和非洲骨關節炎治療市場分為南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區。 2022 年，南非在中東和非洲骨關節炎治療市場佔有率中佔據主導地位。

Estar Technologies Ltd、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc 和 Medi GmbH & Co KG 是中東和非洲骨關節炎治療市場的一些領先公司。

Globally, OA affects more than 500 million people accounting 7% of the world's population according to the CDC report. It represents a major cause of long-term disability. Additionally, osteoarthritis is also more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases. According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among older population. Also, OA can affect anyone, but the condition is most common in adults over 40 years age. Also, The World Health Organization report further reveals that, about 73% of are living with OA are older than 55 years and 60% are female. Thus, with the rising prevalence of OA, new therapy options such as biological therapy are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising treatment for patients suffering from OA. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Transcutaneous Electrical Nerve Stimulation (TENS) is another example of a treatment option to treat OA. TENS helps minimize acute and chronic pains by reducing the need for medications. Therefore, rising prevalence of OA accelerates demand for innovative treatment options, reducing the dependency on medications in the coming years.

Middle East & Africa Osteoarthritis Therapy Market Overview

Middle East & Africa region is segmented as Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa countries. The rising obesity rates, alteration in lifestyles, and dietary patterns are the most influential factors responsible for accelerating demand for osteoarthritis drugs in the Middle East & Africa region. According to the National Institute of Health (NIH) report, osteoarthritis is the most prevalent form of arthritis. In South Africa, in urban settings, it accounted for 55.1%; in rural settings, it ranged from 29.5% to 29.7%, reaching up to 82.7% among the population over 65 years. Physicians suggest several therapeutic options to treat osteoarthritis. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Therefore, the availability of treatment options for osteoarthritis is the major factor responsible for the market growth during the 2022-2030.

Middle East & Africa Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Osteoarthritis Therapy Market Segmentation

The Middle East & Africa osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Middle East & Africa osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Middle East & Africa osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

Based on end user, the Middle East & Africa osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

By country, the Middle East & Africa osteoarthritis therapy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa osteoarthritis therapy market share in 2022.

Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Middle East & Africa osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Middle East & Africa Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Middle East & Africa Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Osteoarthritis Therapy Market - Country Analysis

10.1 Middle East & Africa Market Overview
- 10.1.1 Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Estar Technologies Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DePuy Synthes Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bioventus Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Omron Healthcare Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

簡介目錄圖表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Osteoarthritis Therapy Market